GTX-758
- Generic Name
- GTX-758
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H13F2NO3
- CAS Number
- 938067-78-8
- Unique Ingredient Identifier
- 406GR1485Z
- Background
GTX-758 is under investigation in clinical trial NCT01420861 (GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer).
- Associated Conditions
- -
- Associated Therapies
- -
GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer
- First Posted Date
- 2011-08-22
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- GTx
- Target Recruit Count
- 18
- Registration Number
- NCT01420861
- Locations
- 🇺🇸
GTx Investigative Site, Virginia Beach, Virginia, United States
🇺🇸GTx Investigational Site, Jeffersonville, Indiana, United States
Phase II, Dose Finding Study of GTx-758
- First Posted Date
- 2011-07-13
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- GTx
- Target Recruit Count
- 77
- Registration Number
- NCT01393119
- Locations
- 🇺🇸
GTx Investigative Site, Bala-Cynwyd, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath